DCX and ischemic stroke: To explore whether endogenous neurogenesis was promoted by BHD and/or TPA treatments at day 3 after the ischemic stroke, we used doublecortin (DCX, a marker of newborn neuroblasts) to assess the endogenous neurogenesis.